RXN is currently covered by 4 analysts with average potential upside of $6.27 (15.99%) backed by 49 price targets and 44 ratings. Documented since 01-Jul-2013. Analyst's average stock valuation to be materialised ratio is 84.33% with an average time for price targets to be met of 167.8 days.
Most recent stock forecast was given by JOE RITCHIE from GOLDMAN on 10-Sep-2021.
Highest price target for RXN is 63, Lowest price target is 48, average price target is 55.5.
Currently, out of the existing stock ratings of RXN - 8 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
74
$37.57 (103.13%)
49
1 years 6 months 19 days ago
4/5 (80%)
$2.72 (4.16%)
20
Buy
72
$35.57 (97.64%)
60
1 years 6 months 21 days ago
2/3 (66.67%)
$9.69 (20.34%)
115
Buy
70
$33.57 (92.15%)
66
1 years 7 months 23 days ago
6/8 (75%)
$7.3 (19.70%)
118
Buy
59
$22.57 (61.95%)
57
1 years 8 months 15 days ago
11/11 (100%)
$4.78 (13.21%)
129
Buy
58
$21.57 (59.21%)
52
1 years 11 months ago
10/10 (100%)
$6.85 (22.54%)
457
What is RXN(Rexnord Corporation) average time for price targets to be met?
Which analyst has the current highest performing score on RXN(Rexnord Corporation) with a proven track record?
